{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:21:24Z","timestamp":1782487284689,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94228","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:35:26Z","timestamp":1760031326000},"source":"Crossref","is-referenced-by-count":1,"title":["Clozapine-Induced Toxic Megacolon: A Rare but Serious Complication"],"prefix":"10.7759","author":[{"given":"Erick A","family":"Boldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatin Srinivash","family":"Ramesh Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan V","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Joppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175040","article-title":"Schizophrenia: a narrative review of etiopathogenetic, diagnostic and treatment aspects","volume":"11","author":"Orsolini L","year":"2022","unstructured":"Orsolini L, Pompili S, Volpe U. Schizophrenia: a narrative review of etiopathogenetic, diagnostic and treatment aspects. J Clin Med. 2022, 11:5040. 10.3390\/jcm11175040","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234121","article-title":"A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States","volume":"15","author":"M\u00f8rup MF","year":"2020","unstructured":"M\u00f8rup MF, Kymes SM, Oudin \u00c5str\u00f6m D. A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States. PLoS One. 2020, 15:e0234121. 10.1371\/journal.pone.0234121","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23959","article-title":"Neurobiology of schizophrenia: a comprehensive review","volume":"14","author":"Luvsannyam E","year":"2022","unstructured":"Luvsannyam E, Jain MS, Pormento MK, Siddiqui H, Balagtas AR, Emuze BO, Poprawski T. Neurobiology of schizophrenia: a comprehensive review. Cureus. 2022, 14:e23959. 10.7759\/cureus.23959","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson M","year":"2015","unstructured":"Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015, 72:1172-81. 10.1001\/jamapsychiatry.2015.1737","journal-title":"JAMA Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbt137","article-title":"Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification","volume":"39","author":"Farooq S","year":"2013","unstructured":"Farooq S, Agid O, Foussias G, Remington G. Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification. Schizophr Bull. 2013, 39:1169-72. 10.1093\/schbul\/sbt137","journal-title":"Schizophr Bull"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18com12123","article-title":"Clinical guidance on the identification and management of treatment-resistant schizophrenia","volume":"80","author":"Kane JM","year":"2019","unstructured":"Kane JM, Agid O, Baldwin ML, et al.. Clinical guidance on the identification and management of treatment-resistant schizophrenia. J Clin Psychiatry. 2019, 80:18com12123. 10.4088\/JCP.18com12123","journal-title":"J Clin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind D","year":"2016","unstructured":"Siskind D, McCartney L, Goldschlager R, Kisely S. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2016, 209:385-92. 10.1192\/bjp.bp.115.177261","journal-title":"Br J Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez S","year":"2014","unstructured":"Warnez S, Alessi-Severini S. Clozapine: a review of clinical practice guidelines and prescribing trends. BMC Psychiatry. 2014, 14:102. 10.1186\/1471-244X-14-102","journal-title":"BMC Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0509","article-title":"Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases","volume":"69","author":"Palmer SE","year":"2008","unstructured":"Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry. 2008, 69:759-68. 10.4088\/jcp.v69n0509","journal-title":"J Clin Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract15020033","article-title":"Challenges of constipation in people suffering from schizophrenia: a narrative review","volume":"15","author":"Nagamine T","year":"2025","unstructured":"Nagamine T. Challenges of constipation in people suffering from schizophrenia: a narrative review. Clin Pract. 2025, 15:33. 10.3390\/clinpract15020033","journal-title":"Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2022.24","article-title":"Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017","volume":"220","author":"Handley SA","year":"2022","unstructured":"Handley SA, Every-Palmer S, Ismail A, Flanagan RJ. Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017. Br J Psychiatry. 2022, 220:355-63. 10.1192\/bjp.2022.24","journal-title":"Br J Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201110002-00908","article-title":"Rapidly progressive shock and death from clozapine-induced toxic megacolon: lessons still to be learned","volume":"106","author":"Parakkal D","year":"2011","unstructured":"Parakkal D, DeLemos D, Ehrenpreis E. Rapidly progressive shock and death from clozapine-induced toxic megacolon: lessons still to be learned. Am J Gastroenterol. 2011, 106:S340.","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0391-y","article-title":"The Porirua protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: a pre- and post-treatment study","volume":"31","author":"Every-Palmer S","year":"2017","unstructured":"Every-Palmer S, Ellis PM, Nowitz M, Stanley J, Grant E, Huthwaite M, Dunn H. The Porirua protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: a pre- and post-treatment study. CNS Drugs. 2017, 31:75-85. 10.1007\/s40263-016-0391-y","journal-title":"CNS Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref15","unstructured":"The use of the WHO-UMC system for standardised case causality assessment. (n.d). Accessed. October 9, 2025: https:\/\/www.who.int\/docs\/default-source\/medicines\/pharmacovigilance\/whocausality-assessment.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352231-clozapine-induced-toxic-megacolon-a-rare-but-serious-complication","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:35:27Z","timestamp":1760031327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352231-clozapine-induced-toxic-megacolon-a-rare-but-serious-complication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.94228","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}